BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31812191)

  • 21. The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
    Haarman MG; Douwes JM; Ploegstra MJ; Roofthooft MTR; Vissia-Kazemier TR; Hillege HL; Berger RMF
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1312-1315. PubMed ID: 31298925
    [No Abstract]   [Full Text] [Related]  

  • 22. Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension.
    Morrell NW
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30872557
    [No Abstract]   [Full Text] [Related]  

  • 23. POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes.
    Humbert M; Lau EMT
    Chest; 2019 Dec; 156(6):1039-1042. PubMed ID: 31812188
    [No Abstract]   [Full Text] [Related]  

  • 24. Transthoracic Pulmonary Artery Denervation.
    Ogo T
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):979-981. PubMed ID: 31116607
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary Arterial Hypertension and the Kidney: Getting to the Heart of the Matter.
    Kazory A; Ross EA
    Am J Nephrol; 2018; 47(2):130-133. PubMed ID: 29471304
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Ning
    Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S
    Am J Respir Crit Care Med; 2020 Feb; 201(3):389-391. PubMed ID: 31560564
    [No Abstract]   [Full Text] [Related]  

  • 27. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Pullamsetti SS; de Jesus Perez VA
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
    [No Abstract]   [Full Text] [Related]  

  • 28. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
    Richter MJ; Tello K
    Am J Respir Crit Care Med; 2020 Feb; 201(4):403-405. PubMed ID: 31726011
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary Arterial Hypertension: Too Complex for Physicians, Too Complex for ICD Diagnosis Codes.
    Callahan SJ; Papani R
    Chest; 2019 May; 155(5):1077. PubMed ID: 31060691
    [No Abstract]   [Full Text] [Related]  

  • 30. BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
    Chen L; Liu C; Lu W; Wang T
    Am J Respir Crit Care Med; 2020 May; 201(10):1313. PubMed ID: 32032498
    [No Abstract]   [Full Text] [Related]  

  • 31. A Path Forward for Palliative Care in Pulmonary Arterial Hypertension.
    Sonntag E; Grinnan D
    Chest; 2020 Dec; 158(6):2260-2261. PubMed ID: 33280743
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluating a strategy of PAH therapy pre-treatment in patients with atrial septal defects and pulmonary arterial hypertension to permit safe repair ("treat-and-repair").
    Constantine A; Dimopoulos K
    Int J Cardiol; 2019 Sep; 291():142-144. PubMed ID: 31155330
    [No Abstract]   [Full Text] [Related]  

  • 33. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Grinnan D; Farkas L
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
    [No Abstract]   [Full Text] [Related]  

  • 34. Does Golden Ratio Reside in Pulmonary Circulation?
    Yetkin E; Çuğlan B; Turhan H; Ozturk S
    Chest; 2019 Sep; 156(3):629-630. PubMed ID: 31511152
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of Pulmonary Arterial Hypertension During Qing-Dai Use for the Treatment of Ulcerative Colitis.
    Adachi S; Nakano Y; Kondo T
    Circ J; 2020 Jul; 84(8):1235-1236. PubMed ID: 32655110
    [No Abstract]   [Full Text] [Related]  

  • 36. Imaging risk in pulmonary arterial hypertension.
    Badagliacca R; Vizza CD
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32973075
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply to Chen
    Provencher S; Boucherat O; Berger RMF; Goumans MJ; Bonnet S
    Am J Respir Crit Care Med; 2020 May; 201(10):1313-1314. PubMed ID: 32032495
    [No Abstract]   [Full Text] [Related]  

  • 38. IL-6 in pulmonary hypertension: why novel is not always best.
    Toshner M; Rothman A
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32300021
    [No Abstract]   [Full Text] [Related]  

  • 39. Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al.
    Zhou RP; Wei X; Ma GG; Zhu F; Chen FH; Hu W
    Arthritis Rheumatol; 2019 Apr; 71(4):653-654. PubMed ID: 30281217
    [No Abstract]   [Full Text] [Related]  

  • 40. Response.
    Chemla D; Boulate D; Weatherald J; Lau EMT; Hervé P
    Chest; 2019 Sep; 156(3):630-631. PubMed ID: 31511153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.